​

Funding Round

Series A - Aether Bio

Series A - Aether Bio

Investment Firm

Overview

Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.

Announced Date

Aug 15, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Unless

Unless

Unless is a convertible_note and debt and early_stage_venture and late_stage_venture and secondary_market and seed and venture firm.

Natural Capital

Natural Capital

No designation

Participant Investors

3

Investor Name
Participant InvestorNatural Capital
Participant InvestorAmplifier
Participant InvestorUnless

Round Details and Background

Aether Bio raised $49000000 on 2023-08-15 in Series A

Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2021
Convertible Note - Aether Bio
1-undefined
Nov 02, 2021
Seed Round - Aether Bio
1-undefined
May 01, 2023
Venture Round - Aether Bio
1-93.6K
Aug 15, 2023
Series A - Aether Bio
4-49.0M

Recent Activity

There is no recent news or activity for this profile.